Zobrazeno 1 - 8
of 8
pro vyhledávání: '"de Bono, JS"'
Autor:
Pettitt SJ; The CRUK Gene Function Laboratory, The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, SW3 6JB, UK. Stephen.Pettitt@icr.ac.uk., Shao N; The CRUK Gene Function Laboratory, The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, SW3 6JB, UK., Zatreanu D; The CRUK Gene Function Laboratory, The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, SW3 6JB, UK., Frankum J; The CRUK Gene Function Laboratory, The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, SW3 6JB, UK., Bajrami I; The CRUK Gene Function Laboratory, The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, SW3 6JB, UK., Brough R; The CRUK Gene Function Laboratory, The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, SW3 6JB, UK., Krastev DB; The CRUK Gene Function Laboratory, The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, SW3 6JB, UK., Roumeliotis TI; The Institute of Cancer Research, London, SW3 6JB, UK., Choudhary JS; The Institute of Cancer Research, London, SW3 6JB, UK., Lorenz S; Max Planck Institute for Multidisciplinary Sciences, 37077, Göttingen, Germany., Rust A; The Institute of Cancer Research, London, SW3 6JB, UK., de Bono JS; The Institute of Cancer Research, The Royal Marsden Hospital, Downs Road, Sutton, Surrey, SM2 5PT, UK., Yap TA; The Institute of Cancer Research, The Royal Marsden Hospital, Downs Road, Sutton, Surrey, SM2 5PT, UK.; University of Texas MD Anderson Cancer Center, 1400 Holcombe Blvd, Houston, TX, 77030, USA., Tutt ANJ; The CRUK Gene Function Laboratory, The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, SW3 6JB, UK. Andrew.Tutt@icr.ac.uk., Lord CJ; The CRUK Gene Function Laboratory, The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, SW3 6JB, UK. Chris.Lord@icr.ac.uk.
Publikováno v:
Oncogene [Oncogene] 2023 Sep; Vol. 42 (36), pp. 2701-2709. Date of Electronic Publication: 2023 Jul 25.
Autor:
Mateo J; Vall d'Hebron Institute of Oncology (VHIO), Barcelona; Vall d´Hebron University Hospital, Barcelona, Spain., Lord CJ; The CRUK Gene Function Laboratory; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London., Serra V; Vall d'Hebron Institute of Oncology (VHIO), Barcelona., Tutt A; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London; The Breast Cancer Now Research Unit, Guy's Cancer Centre, Kings College, London., Balmaña J; Vall d'Hebron Institute of Oncology (VHIO), Barcelona; Vall d´Hebron University Hospital, Barcelona, Spain., Castroviejo-Bermejo M; Vall d'Hebron Institute of Oncology (VHIO), Barcelona., Cruz C; Vall d'Hebron Institute of Oncology (VHIO), Barcelona; Vall d´Hebron University Hospital, Barcelona, Spain., Oaknin A; Vall d'Hebron Institute of Oncology (VHIO), Barcelona; Vall d´Hebron University Hospital, Barcelona, Spain., Kaye SB; The Royal Marsden NHS Foundation Trust, London; The Institute of Cancer Research, London, UK., de Bono JS; The Royal Marsden NHS Foundation Trust, London; The Institute of Cancer Research, London, UK. Electronic address: johann.de-bono@icr.ac.uk.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2019 Sep 01; Vol. 30 (9), pp. 1437-1447.
Autor:
Basu B; Department of Oncology, University of Cambridge and Cambridge University Hospitals NHS Foundation Trust, Cambridge., Krebs MG; Manchester Academic Health Science Centre, The University of Manchester and The Christie NHS Foundation Trust, Manchester., Sundar R; Drug Development Unit, The Institute of Cancer Research and The Royal Marsden, London, UK; Department of Haematology-Oncology, National University Health System, Singapore., Wilson RH; Centre for Cancer Research and Cell Biology, Queen's University Belfast and Belfast City Hospital, Belfast., Spicer J; School of Cancer and Pharmaceutical Sciences, King's College London and Guy's and St Thomas' NHS Foundation Trust, London., Jones R; Cardiff University and Velindre Cancer Centre, Cardiff., Brada M; University of Liverpool and Clatterbridge Cancer Centre NHS Foundation Trust, Wirral., Talbot DC; Department of Oncology, Oxford University Hospitals NHS Foundation Trust, Oxford., Steele N; University of Glasgow and Beatson West of Scotland Cancer Centre, Glasgow., Ingles Garces AH; Drug Development Unit, The Institute of Cancer Research and The Royal Marsden, London, UK., Brugger W; Oncology, IMED Biotech Unit AstraZeneca, Cambridge., Harrington EA; Oncology, IMED Biotech Unit AstraZeneca, Cambridge., Evans J; University of Glasgow and Beatson West of Scotland Cancer Centre, Glasgow., Hall E; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London., Tovey H; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London., de Oliveira FM; Division of Clinical Studies, The Institute of Cancer Research, London., Carreira S; Division of Clinical Studies, The Institute of Cancer Research, London., Swales K; Division of Cancer Therapeutics, The Institute of Cancer Research, London., Ruddle R; Drug Development Unit, The Institute of Cancer Research and The Royal Marsden, London, UK; Division of Cancer Therapeutics, The Institute of Cancer Research, London., Raynaud FI; Drug Development Unit, The Institute of Cancer Research and The Royal Marsden, London, UK; Division of Cancer Therapeutics, The Institute of Cancer Research, London., Purchase B; Drug Development Unit, The Institute of Cancer Research and The Royal Marsden, London, UK., Dawes JC; Drug Development Unit, The Institute of Cancer Research and The Royal Marsden, London, UK., Parmar M; Drug Development Unit, The Institute of Cancer Research and The Royal Marsden, London, UK., Turner AJ; Drug Development Unit, The Institute of Cancer Research and The Royal Marsden, London, UK., Tunariu N; Drug Development Unit, The Institute of Cancer Research and The Royal Marsden, London, UK., Banerjee S; Department of Gynae-Oncology, The Royal Marsden, London, UK., de Bono JS; Drug Development Unit, The Institute of Cancer Research and The Royal Marsden, London, UK; Division of Clinical Studies, The Institute of Cancer Research, London., Banerji U; Drug Development Unit, The Institute of Cancer Research and The Royal Marsden, London, UK; Division of Clinical Studies, The Institute of Cancer Research, London; Division of Cancer Therapeutics, The Institute of Cancer Research, London. Electronic address: udai.banerji@icr.ac.uk.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2018 Sep 01; Vol. 29 (9), pp. 1918-1925.
Autor:
George A; Royal Marsden NHS Foundation Trust, Downs Road, London SM2 5PT, UK., Kristeleit R; Royal Marsden NHS Foundation Trust, Downs Road, London SM2 5PT, UK., Rafii S; Royal Marsden NHS Foundation Trust, Downs Road, London SM2 5PT, UK., Michie CO; Royal Marsden NHS Foundation Trust, Downs Road, London SM2 5PT, UK., Bowen R; Royal Marsden NHS Foundation Trust, Downs Road, London SM2 5PT, UK., Michalarea V; Royal Marsden NHS Foundation Trust, Downs Road, London SM2 5PT, UK., van Hagen T; Royal Marsden NHS Foundation Trust, Downs Road, London SM2 5PT, UK., Wong M; Royal Marsden NHS Foundation Trust, Downs Road, London SM2 5PT, UK., Rallis G; Royal Marsden NHS Foundation Trust, Downs Road, London SM2 5PT, UK., Molife LR; Royal Marsden NHS Foundation Trust, Downs Road, London SM2 5PT, UK., Lopez J; Royal Marsden NHS Foundation Trust, Downs Road, London SM2 5PT, UK., Banerji U; Royal Marsden NHS Foundation Trust, Downs Road, London SM2 5PT, UK; The Institute of Cancer Research, Cotswold Road, London SM2 5NG, UK., Banerjee SN; Royal Marsden NHS Foundation Trust, Downs Road, London SM2 5PT, UK., Gore ME; Royal Marsden NHS Foundation Trust, Downs Road, London SM2 5PT, UK., de Bono JS; Royal Marsden NHS Foundation Trust, Downs Road, London SM2 5PT, UK; The Institute of Cancer Research, Cotswold Road, London SM2 5NG, UK., Kaye SB; Royal Marsden NHS Foundation Trust, Downs Road, London SM2 5PT, UK., Yap TA; Royal Marsden NHS Foundation Trust, Downs Road, London SM2 5PT, UK; The Institute of Cancer Research, Cotswold Road, London SM2 5NG, UK. Electronic address: timothy.yap@icr.ac.uk.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2017 May; Vol. 76, pp. 52-59. Date of Electronic Publication: 2017 Mar 06.
Autor:
Ang JE; Authors' Affiliations: The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton; Edinburgh Cancer Research UK Center, Medical Research Council Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Edinburgh; The Cancer Research UK Gene Function Laboratory; Breakthrough Breast Cancer Research Center; Tumour Profiling Unit, The Institute of Cancer Research, London, United Kingdom; University of California San Francisco, San Francisco, California; Department of Medical Oncology, Prince of Wales Clinical School, Prince of Wales Hospital, Sydney, Australia; The Chaim Sheba Medical Center, Tel Hashomer, Israel; Princess Margaret Hospital, Toronto, Canada; Oncologisch Centrum Vrije Universiteit Brussel, Brussels, Belgium; and Dana Farber Cancer Center, Boston, Massachusetts., Gourley C, Powell CB, High H, Shapira-Frommer R, Castonguay V, De Greve J, Atkinson T, Yap TA, Sandhu S, Banerjee S, Chen LM, Friedlander ML, Kaufman B, Oza AM, Matulonis U, Barber LJ, Kozarewa I, Fenwick K, Assiotis I, Campbell J, Chen L, de Bono JS, Gore ME, Lord CJ, Ashworth A, Kaye SB
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2013 Oct 01; Vol. 19 (19), pp. 5485-93. Date of Electronic Publication: 2013 Aug 06.
Autor:
Carden CP; Cancer Research UK Cancer Therapeutics Unit, Division of Cancer Therapeutic, The Institute of Cancer Research, Sutton,United Kingdom., Stewart A, Thavasu P, Kipps E, Pope L, Crespo M, Miranda S, Attard G, Garrett MD, Clarke PA, Workman P, de Bono JS, Gore M, Kaye SB, Banerji U
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2012 Jul; Vol. 11 (7), pp. 1609-17. Date of Electronic Publication: 2012 May 03.
Autor:
Papadatos-Pastos D; Royal Marsden Hospital and Institute of Cancer Research, Sutton, Surrey, UK., Dedes KJ, de Bono JS, Kaye SB
Publikováno v:
The oncologist [Oncologist] 2011; Vol. 16 (10), pp. 1413-21. Date of Electronic Publication: 2011 Sep 23.
Autor:
Fong PC; Drug Development Unit, Royal Marsden National Health Service Foundation Trust, Sutton, Surrey, UK., Yap TA, Boss DS, Carden CP, Mergui-Roelvink M, Gourley C, De Greve J, Lubinski J, Shanley S, Messiou C, A'Hern R, Tutt A, Ashworth A, Stone J, Carmichael J, Schellens JH, de Bono JS, Kaye SB
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2010 May 20; Vol. 28 (15), pp. 2512-9. Date of Electronic Publication: 2010 Apr 20.